These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22855101)

  • 21. Built for the road ahead.
    Mansour A
    Healthc Financ Manage; 2015 Oct; 69(10):76-81. PubMed ID: 26595980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology.
    American Society of Clinical Oncology
    J Oncol Pract; 2014 Jul; 10(4):259-63. PubMed ID: 24737877
    [No Abstract]   [Full Text] [Related]  

  • 23. Out is in; in is out. Reform law lowers drug prices--for outpatient only.
    Lubell J
    Mod Healthc; 2010 May; 40(18):12-3. PubMed ID: 20476536
    [No Abstract]   [Full Text] [Related]  

  • 24. PhRMA sues on 340B orphans.
    Lee J
    Mod Healthc; 2013 Oct; 43(40):17. PubMed ID: 24340726
    [No Abstract]   [Full Text] [Related]  

  • 25. Protect the 340B drug program.
    Hart C
    Mod Healthc; 2014 Feb; 44(7):24. PubMed ID: 24660395
    [No Abstract]   [Full Text] [Related]  

  • 26. Final notice regarding section 602 of the Veterans Health Care Act of 1992 entity guidelines--PHS. Final notice.
    Fed Regist; 1994 May; 59(92):25110-4. PubMed ID: 10134125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risks to the 340B Drug Pricing Program Related to Manufacturer Restrictions on Drug Availability.
    Knox RP; Kesselheim AS; Sarpatwari A
    JAMA; 2022 May; 327(17):1647-1648. PubMed ID: 35426909
    [No Abstract]   [Full Text] [Related]  

  • 28. An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.
    Sarpatwari A; Avorn J; Kesselheim AS
    JAMA; 2018 Jun; 319(23):2373-2374. PubMed ID: 29800027
    [No Abstract]   [Full Text] [Related]  

  • 29. What's at stake in effort to diminish 340B program.
    Henkel B
    Mod Healthc; 2014 Sep; 44(39):34. PubMed ID: 25509599
    [No Abstract]   [Full Text] [Related]  

  • 30. Growing pains. Insurers and PbMs want in on 340B savings.
    Lee J
    Mod Healthc; 2012 Mar; 42(11):10. PubMed ID: 22462315
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmaceuticals and medical devices: cost savings.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-20. PubMed ID: 19297717
    [No Abstract]   [Full Text] [Related]  

  • 32. A prescription for change.
    Testoni M
    Healthc Financ Manage; 2015 Oct; 69(10):30, 32. PubMed ID: 26595972
    [No Abstract]   [Full Text] [Related]  

  • 33. New Medicare bill targets discrepancies in fees for cancer drugs, outpatient services.
    Twombly R
    J Natl Cancer Inst; 2004 Feb; 96(3):166-8. PubMed ID: 14759976
    [No Abstract]   [Full Text] [Related]  

  • 34. Notice regarding Section 602 of the Veterans Health Care Act of 1992; new drug pricing--PHS. Final notice.
    Fed Regist; 1995 Oct; 60(190):51488-9. PubMed ID: 10151188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical industry pricing practices: impact of the Bayer settlement.
    Berkle M
    Health Care Law Mon; 2001 Jul; ():3-11. PubMed ID: 11484634
    [No Abstract]   [Full Text] [Related]  

  • 36. [Discount contracts between industry and public health insurance. Analog insulin preparations still reimbursable].
    Schmidt K
    MMW Fortschr Med; 2006 Nov; 148(48):60. PubMed ID: 17615776
    [No Abstract]   [Full Text] [Related]  

  • 37. Cost consequences of the 340B drug discount program.
    Conti RM; Bach PB
    JAMA; 2013 May; 309(19):1995-6. PubMed ID: 23609758
    [No Abstract]   [Full Text] [Related]  

  • 38. AWP reimbursement scrutinized by several states.
    Carroll J
    Manag Care; 2003 Apr; 12(4):11-2. PubMed ID: 12747021
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-27. PubMed ID: 18345555
    [No Abstract]   [Full Text] [Related]  

  • 40. Maintaining qualification for 340B.
    Gricius RF; Wong D
    Healthc Financ Manage; 2016 Mar; 70(3):70-5. PubMed ID: 27183761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.